← Leaderboards
Eric R Houpt
University Of Virginia
$18,307,652
Attributed
$20,418,326
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,150,791 · 14
CDC$267,535 · 1
By mechanism
R01$8,728,301 · 3
U01$6,061,488 · 2
K24$1,548,070 · 1
R42$958,924 · 1
R21$785,033 · 2
D43$735,178 · 1
Top collaborators
- Scott K Heysell6 shared
- Crystal R Icenhour2 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Scott K Heysell$9,245,019
- Ryan Llewellyn$89,013
- Jennifer A Mohawk$81,416
Others in their field
Top investigators on “Virginia”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Andrzej Joachimiak Joachimiak · University Of Chicago$84,030,440
- Gerald Van Belle · University Of Washington$42,863,319
- Frederick Gerard Moeller · Virginia Commonwealth University$40,922,178
- Gary O. Rankin · Marshall University$37,697,977
- Eugene C. Somoza · University Of Cincinnati$33,598,102
Research focus
VirginiaDiagnosticUniversitiesBaseAreaResearch PersonnelSiteProgramsPredispositionMolecularInfectionTanzaniaPathogenDiagnosisPharmaceutical PreparationsCollaborationsDrug ResistanceFundingFutureCommunicable DiseasesLaboratoriesSpecimenDetectionMultidrug-Resistant Tuberculosis
Grant awards (55)
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome$589,122
R01 · FY2025 · HL · contact PI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome$578,396
R01 · FY2024 · HL · contact PI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome$673,634
R01 · FY2023 · HL · contact PI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome$675,436
R01 · FY2022 · HL · contact PI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases$157,566
K24 · FY2022 · AI · contact PI
Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome$721,114
R01 · FY2021 · HL · contact PI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases$157,566
K24 · FY2021 · AI · contact PI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases$157,566
K24 · FY2020 · AI · contact PI
Diagnostics and Pharmacotherapy for Severe Forms of TB$648,811
U01 · FY2019 · AI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases$157,566
K24 · FY2019 · AI · contact PI
Diagnostics and Pharmacotherapy for Severe Forms of TB$656,184
U01 · FY2018 · AI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Diseases$157,566
K24 · FY2018 · AI · contact PI
Diagnostics and Pharmacotherapy for Severe Forms of TB$657,815
U01 · FY2017 · AI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea$152,048
K24 · FY2017 · AI · contact PI
Diagnostics and Pharmacotherapy for Severe Forms of TB$673,914
U01 · FY2016 · AI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea$152,048
K24 · FY2016 · AI · contact PI
Tuberculosis Second Line Drug Susceptibility Chip$787,280
R01 · FY2015 · AI · contact PI
Diagnostics and Pharmacotherapy for Severe Forms of TB$384,700
U01 · FY2015 · AI · contact PI
Global Health Security Partner Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally$267,535
U2G · FY2015 · GH · contact PI
Genotyping and Pharmacokinetics in the HIV/MDR-TB epidemic of Eastern Siberia$182,875
R21 · FY2015 · AI · contact PI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea$152,048
K24 · FY2015 · AI · contact PI
Tuberculosis Second Line Drug Susceptibility Chip$787,280
R01 · FY2014 · AI · contact PI
Reduced Injectable, Short-course for (E)Xpert MDR-TB [RISE trial]$241,000
R34 · FY2014 · AI
Genotyping and Pharmacokinetics in the HIV/MDR-TB epidemic of Eastern Siberia$196,175
R21 · FY2014 · AI · contact PI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea$152,048
K24 · FY2014 · AI · contact PI
Global Infectious Disease Research Training Program Award$144,934
D43 · FY2014 · TW · contact PI
Tuberculosis Second Line Drug Susceptibility Chip$740,042
R01 · FY2013 · AI · contact PI
Molecular Diagnostic Tools for Patient Oriented Field Studies in Infectious Disea$152,048
K24 · FY2013 · AI · contact PI
Global Infectious Disease Research Training Program Award$141,945
D43 · FY2013 · TW · contact PI
Tuberculosis Second Line Drug Susceptibility Chip$787,280
R01 · FY2012 · AI · contact PI
Global Infectious Disease Research Training Program Award$149,416
D43 · FY2012 · TW · contact PI
Tuberculosis Second Line Drug Susceptibility Chip$920,643
R01 · FY2011 · AI · contact PI
Comprehensive Molecular Diagnosis for Food and Waterborne Enteropathogens$345,626
U01 · FY2011 · AI · contact PI
Global Infectious Disease Research Training Program Award$149,416
D43 · FY2011 · TW · contact PI
Comprehensive Molecular Diagnosis for Food and Waterborne Enteropathogens$650,583
U01 · FY2010 · AI · contact PI
Global Infectious Disease Research Training Program Award$149,467
D43 · FY2010 · TW · contact PI
Comprehensive Molecular Diagnosis for Food and Waterborne Enteropathogens$113,241
U01 · FY2010 · AI · contact PI
Comprehensive Molecular Diagnosis for Food and Waterborne Enteropathogens$638,012
U01 · FY2009 · AI · contact PI
Real-time PCR Diagnostic Kit for Giardia and Cryptosporidium$405,066
R42 · FY2009 · AI
Mouse Strain dependent innate resistance to intestinal amebiasis$360,779
R01 · FY2009 · AI · contact PI
Comprehensive Molecular Diagnosis for Food and Waterborne Enteropathogens$772,780
U01 · FY2008 · AI · contact PI
Real-time PCR Diagnostic Kit for Giardia and Cryptosporidium$553,858
R42 · FY2008 · AI
Mouse Strain dependent innate resistance to intestinal amebiasis$360,779
R01 · FY2008 · AI · contact PI
Comprehensive Molecular Diagnosis for Food and Waterborne Enteropathogens$519,822
U01 · FY2007 · AI · contact PI
Mouse Strain dependent innate resistance to intestinal amebiasis$367,766
R01 · FY2007 · AI · contact PI
Targeted DNA extraction for Tuberculosis PCR from sputum$275,497
R41 · FY2007 · AI · contact PI
Multiplex bead-PCR diagnosis for AIDS diarrhea$183,883
R21 · FY2007 · AI · contact PI
Mucosal immune regulation in murine amebic colitis$122,445
K08 · FY2007 · AI · contact PI
Mouse Strain dependent innate resistance to intestinal amebiasis$378,750
R01 · FY2006 · AI · contact PI
Real-time PCR diagnostic kit for Giardia and Cryptosporidium$226,675
R41 · FY2006 · AI · contact PI
Multiplex bead-PCR diagnosis for AIDS diarrhea$222,100
R21 · FY2006 · AI · contact PI
Mucosal immune regulation in murine amebic colitis$122,445
K08 · FY2006 · AI · contact PI
Mucosal immune regulation in murine amebic colitis$122,445
K08 · FY2005 · AI
Mucosal immune regulation in murine amebic colitis$111,645
K08 · FY2004 · AI
Mucosal immune regulation in murine amebic colitis$111,645
K08 · FY2003 · AI